“The national health system would have a great advantage in prevention against the respiratory syncytial virus. Highly effective vaccination against RSV could reduce public health costs.” This was said by Full Professor of Infectious Diseases at the “Tor Vergata” University of Rome and scientific director of the Italian Society of Infectious and Tropical Diseases, Massimo Andreoni on the sidelines of an event on the respiratory syncytial virus held in Rome.
#Health #Andreoni #Simit #vaccines #RSV #reduction #expenses #NHS
